heartofcovid

The long cardiovascular tail of the pandemic

by: Amitava Banerjee The countries which have been unable to suppress SARS-CoV-2 infection rate have had to focus health systems and resources on the acute hospitalised phase of COVID-19, particularly in the intensive care unit. However, most hospital care of COVID is not in intensive care, and most COVID patients, even in high-income settings, areContinue reading “The long cardiovascular tail of the pandemic”

Do COVID STEMIs have a higher thrombus burden? More questions & implications

by:Aaysha Cader Whilst much has been written about COVID-19 and its inflammation-thrombosis-hypercoagulability cascade, this has to a large extent focused on venous thromboembolism (VTE). As more data emerges, it is evident that the intense inflammatory response associated with SARS-COV-2 infection may trigger thrombosis across multiple vascular beds, with large thrombus burden in ST-segment elevation myocardialContinue reading “Do COVID STEMIs have a higher thrombus burden? More questions & implications”

Cardiac rehabilitation in the time of COVID19

by:Abraham Samuel Babu Cardiac rehabilitation (CR) is an integral part of cardiovascular care. Yet, it is one of the most underutilised evidence based intervention across the world.1 With uptake to CR varying greatly around the world, the novel 2019 coronavirus (COVID19), has been no help to this. Nevertheless, this has brought the entire CR communityContinue reading “Cardiac rehabilitation in the time of COVID19”

Heart failure and COVID-19: A dynamic and changing interaction

by:Eduardo Chuquiure-Valenzuela In several COVID-19 cases, acute myocarditis results in focal or global myocardial inflammation, necrosis1. Clinically presents ventricular dysfunction and tachyarrhythmias2-3. Also, may influence in cardiac contractile worsening with a severe impact on Heart Failure (HF). It is postulated that Heart Failure risk is mediated by a decrease in myocardial oxygen supply caused byContinue reading “Heart failure and COVID-19: A dynamic and changing interaction”

Virtual health and COVID-19: Is this the future of cardiovascular disease care delivery?

by:Lilian Mbau With the ongoing COVID-19 pandemic, virtual health is being embraced more than ever (1). This is especially so for cardiovascular disease (CVD) care because patients with underlying conditions such as CVD or associated risk factors have an increased risk of dying from COVID-19 infection (2). In addition, virtual health provides an option forContinue reading “Virtual health and COVID-19: Is this the future of cardiovascular disease care delivery?”

The indirect consequences of COVID-19

by:Alice M. Jackson The direct impact of the COVID-19 pandemic is easily measured, with many countries reporting the daily number of hospitalisations and fatalities attributed to the disease. Excess deaths (deaths within the total death toll above those that would have been expected if the crisis had not occurred) represent both the direct and theContinue reading “The indirect consequences of COVID-19”

Ethnicity, cardiovascular disease and COVID-19 in the UK

by:Alice M. Jackson Soon after the first death of a UK health care worker linked to COVID-19 was reported at the end of March, an alarming trend quickly appeared – the majority of those dying on the front line were from an ethnic minority. To date, just under two-thirds have been from a Black, AsianContinue reading “Ethnicity, cardiovascular disease and COVID-19 in the UK”

Do hypertension patients have high risk for COVID-19 ?

by:Eduardo Chuquiure-Valenzuela Recent studies about COVID-19 patients have reported that hypertension is associated with higher in-hospital complications and mortality. Also, worse results in angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARBs) were hypothesized. There was uncertainty about initial clinical studies solidity. Most of cardiologic societies around the world, advise to continue ACEI andContinue reading “Do hypertension patients have high risk for COVID-19 ?”

EMPTY HOSPITALS: ARE WE CREATING A TICKING TIME BOMB FOR CARDIOVASCULAR DISEASE PATIENTS

by:Lilian Mbau A lot has been discussed about the interaction between coronavirus disease of 2019 (COVID-19) and Cardiovascular Diseases (CVDs) with more focus on the effect of COVID-19 on patients with CVDs as well as the cardiovascular (CV) complications resulting from COVID-19 infection. Patients with underlying conditions such as CVD or associated risk factors haveContinue reading “EMPTY HOSPITALS: ARE WE CREATING A TICKING TIME BOMB FOR CARDIOVASCULAR DISEASE PATIENTS”

Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies? by: Darryl Leong Should cardiovascular disease comorbidity scare you during the COVID-19 season?by: Jeemon Panniyammakal Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in Chinaby: Lucrecia M. Burgos The link between smoking and COVID 19; should we wait for more evidenceContinue reading “Table of Contents”